Literature DB >> 15549020

Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.

.   

Abstract

Acinetobacter baumannii is a well known but relatively uncommon cause of health-care--associated infections. Because the organism has developed substantial antimicrobial resistance, treatment of infections attributed to A. baumannii has become increasingly difficult This report describes an increasing number of A. baumannii bloodstream infections in patients at military medical facilities in which service members injured in the Iraq/Kuwait region during Operation Iraqi Freedom (OIF) and in Afghanistan during Operation Enduring Freedom (OEF) were treated. The number of these infections and their resistance to multiple antimicrobial agents underscore 1) the importance of infection control during treatment in combat and health-care settings and 2) the need to develop new antimicrobial drugs to treat these infections.

Entities:  

Mesh:

Year:  2004        PMID: 15549020

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  71 in total

1.  In vitro and in vivo activities of E-101 solution against Acinetobacter baumannii isolates from U.S. military personnel.

Authors:  G A Denys; J C Davis; P D O'Hanley; J T Stephens
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  KatG and KatE confer Acinetobacter resistance to hydrogen peroxide but sensitize bacteria to killing by phagocytic respiratory burst.

Authors:  Daqing Sun; Sara A Crowell; Christian M Harding; P Malaka De Silva; Alistair Harrison; Dinesh M Fernando; Kevin M Mason; Estevan Santana; Peter C Loewen; Ayush Kumar; Yusen Liu
Journal:  Life Sci       Date:  2016-02-06       Impact factor: 5.037

4.  Perceived stress, heart rate, and blood pressure among adolescents with family members deployed in Operation Iraqi Freedom.

Authors:  Vernon A Barnes; Harry Davis; Frank A Treiber
Journal:  Mil Med       Date:  2007-01       Impact factor: 1.437

Review 5.  Acinetobacter pneumonia: a review.

Authors:  Joshua D Hartzell; Andrew S Kim; Mark G Kortepeter; Kimberly A Moran
Journal:  MedGenMed       Date:  2007-07-05

Review 6.  Multidrug-resistant organisms in military wounds from Iraq and Afghanistan.

Authors:  Jason H Calhoun; Clinton K Murray; M M Manring
Journal:  Clin Orthop Relat Res       Date:  2008-03-18       Impact factor: 4.176

7.  The importance of militaries from developing countries in global infectious disease surveillance.

Authors:  Jean-Paul Chretien; David L Blazes; Rodney L Coldren; Michael D Lewis; Jariyanart Gaywee; Khunakorn Kana; Narongrid Sirisopana; Victor Vallejos; Carmen C Mundaca; Silvia Montano; Gregory J Martin; Joel C Gaydos
Journal:  Bull World Health Organ       Date:  2007-03       Impact factor: 9.408

8.  Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis.

Authors:  Daniel P Crane; Kirill Gromov; Dan Li; Kjeld Søballe; Christian Wahnes; Hubert Büchner; Matthew J Hilton; Regis J O'Keefe; Clinton K Murray; Edward M Schwarz
Journal:  J Orthop Res       Date:  2009-08       Impact factor: 3.494

9.  Impact of Operational Theater on Combat and Noncombat Trauma-Related Infections.

Authors:  David R Tribble; Ping Li; Tyler E Warkentien; Bradley A Lloyd; Elizabeth R Schnaubelt; Anuradha Ganesan; William Bradley; Deepak Aggarwal; M Leigh Carson; Amy C Weintrob; Clinton K Murray
Journal:  Mil Med       Date:  2016-10       Impact factor: 1.437

10.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.